Dr Lal Pathlabs - Dr. Lal Pathlabs Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Dr Lal Pathlabs - Dr. Lal Pathlabs Share Price

1,598.1029.40 (1.88%)

Live
As On: 11 Jun, 2026, 11:31 AM IST
As On: 11 Jun, 2026, 11:31 AM IST

Sector: Hospitals & All...
Industry: Diagnostics

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,555.00
High	1,624.80
Low	1,555.00
Prev Close	1,568.70
Volume	2,29,234
VWAP(₹)	1,599.95

Key Metrics

PE Ratio(x)	53.11
EPS - TTM(₹)	30.13
MCap(₹ Cr.)	26,825.56
MCap Rank	8
PB Ratio(x)	10.34
Div Yield(%)	1.50
Face Value(₹)	10.00
52W High(₹)	1,770.00
52W Low(₹)	1,272.60
MCap/Sales	7.97
Beta(1 Month)	1.34
BV/Share(₹)	151.67

Dr Lal Pathlabs share price insights

Dividend Announcement
Company announced a dividend of Rs 4.0 per share on Apr 30, 2026 with record date of Jun 26, 2026.
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 18.22% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Dr Lal Pathlabs Share Price Update
Dr. Lal Pathlabs Ltd. share price moved up by 1.88% from its previous close of Rs 1,568.70. Dr. Lal Pathlabs Ltd. stock last traded price is 1,598.10
Share Price Value
Today/Current/Last 1,598.101,597.50
Previous Day 1,568.701,570.60

Found Insights useful?

Dr Lal Pathlabs Share Price Returns

1 Day	1.88%
1 Month	-3.29%
3 Months	13.77%
1 Year	7.07%
3 Years	63.43%
5 Years	-0.57%

Dr Lal Pathlabs Share Recommendations

Mean recosCurrent

BUY

25 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	9	9	8	6
Buy	12	12	12	11
Hold	1	1	1	1
Sell	3	3	3	3
Strong Sell	-	-	-	2
# Analysts	25	25	24	23

Recent Recos

Target₹2910
OrganizationHDFC Securities
ADD

Target₹3600
OrganizationJM Financial
BUY

Target₹3181
OrganizationBNP Paribas Securities
BUY

View all Stock Recommendations

News & Analysis

View all Dr Lal Pathlabs Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	726.70	684.20	755.40	697.90	628.40
Total Income Growth (%)	6.21	-9.43	8.24	11.06	1.06
Total Expenses	560.50	552.70	547.00	512.10	470.00
Total Expenses Growth (%)	1.41	1.04	6.82	8.96	-1.71
EBIT	166.20	131.50	208.40	185.80	158.40
EBIT Growth (%)	26.39	-36.90	12.16	17.30	10.31
Profit after Tax (PAT)	131.30	90.50	150.60	132.40	154.80
PAT Growth (%)	45.08	-39.91	13.75	-14.47	60.08
EBIT Margin (%)	22.87	19.22	27.59	26.62	25.21
Net Profit Margin (%)	18.07	13.23	19.94	18.97	24.63
Basic EPS (₹)	7.86	5.42	18.05	15.88	18.57

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	712.20	658.70	722.40	667.00	602.40
Total Income Growth (%)	8.12	-8.82	8.31	10.72	8.03
Total Expenses	536.40	528.60	523.00	490.10	452.70
Total Expenses Growth (%)	1.48	1.07	6.71	8.26	12.72
EBIT	175.80	130.10	199.40	176.90	149.70
EBIT Growth (%)	35.13	-34.75	12.72	18.17	-4.04
Profit after Tax (PAT)	141.10	92.10	145.70	129.30	148.40
PAT Growth (%)	53.20	-36.79	12.68	-12.87	29.61
EBIT Margin (%)	24.68	19.75	27.60	26.52	24.85
Net Profit Margin (%)	19.81	13.98	20.17	19.39	24.63
Basic EPS (₹)	8.45	5.52	17.46	15.51	17.80

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,864.20	2,554.83	2,295.81	2,058.60	2,139.95
Total Revenue Growth (%)	12.11	11.28	11.52	-3.80	31.08
Total Expenses	2,165.00	1,930.03	1,790.36	1,714.77	1,664.97
Total Expenses Growth (%)	12.17	7.80	4.41	2.99	34.47
Profit after Tax (PAT)	504.80	487.14	357.74	238.85	344.83
PAT Growth (%)	3.63	36.17	49.78	-30.74	18.25
Operating Profit Margin (%)	26.13	26.29	24.01	18.90	24.20
Net Profit Margin (%)	18.27	19.79	16.06	11.84	16.51
Basic EPS (₹)	30.24	58.48	43.05	28.82	41.70

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,760.30	2,463.14	2,026.86	1,815.63	1,925.72
Total Revenue Growth (%)	12.06	21.52	11.63	-5.72	24.90
Total Expenses	2,070.00	1,841.86	1,510.89	1,424.80	1,466.33
Total Expenses Growth (%)	12.39	21.91	6.04	-2.83	25.57
Profit after Tax (PAT)	508.20	497.26	384.37	292.36	344.05
PAT Growth (%)	2.20	29.37	31.47	-15.03	22.83
Operating Profit Margin (%)	26.90	27.33	27.59	24.03	26.05
Net Profit Margin (%)	19.19	21.14	19.54	16.52	18.37
Basic EPS (₹)	30.45	59.70	46.25	35.28	41.61

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 18.22% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,146.00	2,716.79	2,455.96	2,385.56	2,353.22
Total Assets Growth (%)	15.80	10.62	2.95	1.37	41.65
Total Liabilities	604.70	510.31	570.60	686.02	809.55
Total Liabilities Growth (%)	18.50	-10.57	-16.82	-15.26	110.17
Total Equity	2,541.30	2,206.48	1,885.36	1,699.55	1,543.54
Total Equity Growth (%)	15.17	17.03	10.93	10.11	20.97
Current Ratio (x)	3.48	3.39	2.42	2.07	1.75
Total Debt to Equity (x)	0.00	0.00	0.05	0.14	0.23
Contingent Liabilities	0.00	21.37	20.29	18.28	25.99

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,049.20	2,620.95	2,415.44	2,320.17	2,213.92
Total Assets Growth (%)	16.34	8.51	4.11	4.80	40.74
Total Liabilities	576.30	486.72	515.78	630.31	737.45
Total Liabilities Growth (%)	18.40	-5.63	-18.17	-14.53	107.15
Total Equity	2,472.90	2,134.23	1,899.66	1,689.86	1,476.47
Total Equity Growth (%)	15.87	12.35	12.42	14.45	21.31
Current Ratio (x)	3.44	3.29	2.17	1.87	1.55
Total Debt to Equity (x)	0.00	0.00	0.04	0.14	0.23
Contingent Liabilities	0.00	21.33	20.23	18.01	25.99

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	635.70	568.89	535.33	456.03	446.69
Net Cash used in Investing Activities	-421.90	-303.16	-24.27	-287.31	-449.25
Net Cash flow from Financing Activities	-263.60	-334.03	-413.86	-283.18	136.45
Net Cash Flow	-49.80	-68.31	97.20	-114.46	133.90
Closing Cash & Cash Equivalent	242.80	292.63	360.93	263.73	378.20
Closing Cash & Cash Equivalent Growth (%)	-17.03	-18.93	36.86	-30.27	54.81
Total Debt/ CFO (x)	0.00	0.00	0.16	0.52	0.77

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	605.90	540.00	477.60	427.53	423.81
Net Cash used in Investing Activities	-382.10	-293.00	31.91	-288.47	-448.50
Net Cash flow from Financing Activities	-256.00	-324.75	-404.00	-270.05	142.04
Net Cash Flow	-32.20	-77.75	105.51	-130.99	117.34
Closing Cash & Cash Equivalent	234.40	266.60	325.83	220.32	349.01
Closing Cash & Cash Equivalent Growth (%)	-12.08	-18.18	47.89	-36.87	50.65
Total Debt/ CFO (x)	0.00	0.00	0.17	0.55	0.82

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 421.9 cr for investing activities which is an YoY increase of 39.17%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	20.12	22.42	19.34	14.33	22.86
Return on Capital Employed (%)	26.78	27.95	26.86	19.90	27.25
Return on Assets (%)	16.04	17.93	14.56	10.01	14.65
Interest Coverage Ratio (x)	38.76	35.37	23.11	14.16	20.32
Asset Turnover Ratio (x)	0.94	0.95	0.92	0.85	0.97
Price to Earnings (x)	43.67	42.55	52.91	64.10	63.29
Price to Book (x)	8.78	9.53	10.21	9.15	14.41
EV/EBITDA (x)	23.92	25.23	26.79	27.92	35.05
EBITDA Margin (%)	31.98	32.05	30.46	26.35	29.37

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	20.55	23.29	20.23	17.30	23.30
Return on Capital Employed (%)	27.24	28.79	27.26	22.52	27.65
Return on Assets (%)	16.66	18.97	15.91	12.60	15.54
Interest Coverage Ratio (x)	39.38	36.14	23.08	14.75	19.74
Asset Turnover Ratio (x)	0.93	0.93	0.83	0.78	0.99
Price to Earnings (x)	43.48	41.67	49.26	52.36	63.29
Price to Book (x)	8.90	9.71	9.94	9.02	14.72
EV/EBITDA (x)	24.44	25.67	29.53	29.45	38.23
EBITDA Margin (%)	32.72	33.03	31.49	28.67	30.07

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
44%
Positive Movement
since 1st Jan 2005
on basis
55%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 1593.70 Pivot
1577.90
S1 1552.90
R2 1618.70 S2 1537.10
R3 1659.50 S3 1496.30
Average True Range
5 Days 14 Days 28 Days
50.85 54.76 53.81

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Dr Lal Pathlabs	53.16	10.56	20.12	26.78	16.04	11.51	26.13	18.45	30.24	3.48	0.00	0.00
Vijaya Diagnostic	76.75	13.85	18.07	19.22	11.47	20.60	32.65	21.24	16.81	2.60	0.00	0.00
Metropolis Health	57.54	7.17	12.55	16.22	8.88	12.70	17.78	11.61	9.19	1.40	0.01	0.05
Thyrocare Tech.	51.35	14.29	27.84	34.59	21.81	16.32	26.59	19.47	10.27	3.39	0.00	0.00
Krsnaa Diagnostics	17.17	1.78	10.34	10.64	5.56	17.05	21.32	13.13	31.29	2.68	0.55	3.73
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 8,91,62,270 53.21 % 0.00
Pledge 0 0.00 % 0.00
FII 2,87,88,558 17.18 % -3.11
DII 3,55,85,868 21.23 % 2.17
MF 3,12,02,292 18.62 % 1.78
Others 1,40,18,324 8.37 % 0.93
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 53.21 53.21 53.21 53.79
Pledge 0.00 0.00 0.00 0.00
FII 17.18 20.29 21.86 21.68
DII 21.23 19.06 18.06 17.49
Mutual Funds 18.62 16.84 15.90 15.04
Others 8.37 7.43 6.87 7.04

Mutual Funds Ownership

MF Ownership as on 30 April 2026

HDFC Flexi Cap Direct-G
Equity: Flexi Cap
5
- 571.28
  Amount Invested (in Cr.)
- 0.57%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Flexi Cap Direct-G
Equity: Flexi Cap
1
- 350.04
  Amount Invested (in Cr.)
- 1.579051%
  % of AUM
- 0.00
  % Change (MoM basis)
Aditya Birla SL Flexi Cap Direct-G
Equity: Flexi Cap
4
- 248.83
  Amount Invested (in Cr.)
- 0.97079885%
  % of AUM
- 7.24
  % Change (MoM basis)

View all Mutual Fund Schemes

Dr Lal Pathlabs Futures & Options

Options
Futures
- Expiry MonthPlease select expiry month:
Date Price Open Interest
-- (-%)
-- (-%)
-
Open
-
High
-
Low
-
Prev Close
-
Contracts Traded
-
Turnover (₹ Lakhs)
Open Interest as of

Dr Lal Pathlabs Top Searches

Corporate Actions

Recent
General Meeting
-
Apr 30, 2026
Final
40%
Apr 30, 2026
Board Meeting
Audited Results & Final Dividend
Apr 23, 2026

Announced on	Meeting on
Apr 23, 2026	Apr 30, 2026
Audited Results & Final Dividend
Jan 23, 2026	Jan 30, 2026
Quarterly Results & Interim Dividend
Oct 24, 2025	Oct 31, 2025
Qtr Results, Int.Dividend & Bonus issue
Jul 24, 2025	Jul 31, 2025
Quarterly Results, Dividend & Others
Apr 21, 2025	Apr 25, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Apr 30, 2026 Jun 25, 2026 40%
Jan 30, 2026 Feb 05, 2026 35%
Oct 31, 2025 Nov 07, 2025 70%
Jul 31, 2025 Aug 06, 2025 60%
Apr 25, 2025 Jun 06, 2025 60%
Bonus
Announced on Ex-Date
Oct 31, 2025 Dec 19, 2025
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Apr 30, 2026 Jul 25, 2026
-
Nov 07, 2025 Dec 09, 2025
-
Apr 25, 2025 Jun 28, 2025
-
Feb 07, 2025 Mar 11, 2025
-
May 10, 2024 Jun 29, 2024
-

About Dr Lal Pathlabs

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 26,284.36 Crore) operating in Hospitals & Allied Services sector.

Dr. Lal Pathlabs Ltd. key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 726.70 Crore, up 6.21 % from last quarter Total Income of Rs 684.20 Crore and up 15.64 % from last year same quarter Total Income of Rs 628.40 Crore. Company has reported net profit after tax of Rs 132.20 Crore in latest quarter.

The company’s top management includes Brig.(Hony) Dr.Arvind Lal, Mr.Shankha Banerjee, Dr.Vandana Lal, Dr.Archana Lal Erdmann, Mr.Rahul Sharma, Mr.Arun Duggal, Mr.Gurinder Singh Kalra, Mr.Rajit Mehta, Mr.Rohit Bhasin, Mrs.Somya Satsangi, Mr.Ved Prakash Goel, Mr.Vinay Gujral. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2026, the company has a total of 16.76 Crore shares outstanding.

Dr Lal Pathlabs Share Price Today is Rs. 1598.10. On previous day, the Dr Lal Pathlabs Share Price (NSE) closed at Rs. 1575.8, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 53.21% of the stake in Dr Lal Pathlabs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Dr Lal Pathlabs stocks was 17.18% as compared to 20.29% in Dec 2025 with decrease of 3.11%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 21.23% as compared to 19.06% in Dec 2025 with increase of 2.17%. Out of the total DII holdings in Dr Lal Pathlabs shares 18.62% was held by mutual funds. The rest including public held is 8.38%. Dr Lal Pathlabs stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Dr Lal Pathlabs Dividend: Ever since 1995, Dr Lal Pathlabs dividends has been paid out around 27 times. As on 11 Jun, 2026, 11:31 AM IST, The overall dividend yield for Dr Lal Pathlabs stands at 1.53%. The last dividend paid was on June 25, 2026 (Rs. 4.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 30.13.

Dr Lal Pathlabs Bonus: The most recent bonus issue had been in year December 19, 2025 around 0 years ago at 1 : 1 ratio. The first bonus issue was announced in Oct 2025.

Stock Forecast:
After showing 726.7 Cr. of sales and 6.21% of quarterly net profit, there have been multiple ups and downs in the Dr Lal Pathlabs stock prices in the past few weeks. For example, Dr Lal Pathlabs stock price on 3rd of June 2026 was around Rs. 1569.6. Dr Lal Pathlabs share price now stands at an average of Rs. 1598.10. Judging by last week's performance, stock is in up trend.

Dr Lal Pathlabs has a median target price of Rs. 1681.68 in 12 months by 25 analysts. They have provided a high estimate of Rs. 2072.0 and low estimate of Rs. 1180.0 for Dr Lal Pathlabs share.

Historical Prices and Performance:
Dr Lal Pathlabs, incorporated in 1995 is a Mid Cap company (with a market cap of Rs. 26284.36) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Dr Lal Pathlabs stock was 20.12%, 22.42%, 19.34%, 14.33% and 22.86% respectively.
The Dr Lal Pathlabs share gave a 3 year return of 60.43% as compared to Nifty 50 which gave a return of 25.06%.
Dr Lal Pathlabs announced 40.0% final dividend on June 25, 2026.

Key Metrics:
PE Ratio of Dr Lal Pathlabs is 52.07
Prices/Sales Ratio of Dr Lal Pathlabs is 7.97
Price/Book Ratio of Dr Lal Pathlabs is 10.34

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Dr Lal Pathlabs, major competitors and peers include Vijaya Diagnostic, Metropolis Health, Thyrocare Tech. and Krsnaa Diagnostics. As of Dec 2025, the dividend yield of Dr Lal Pathlabs stands at 1.53% while Vijaya Diagnostic, Metropolis Health, Thyrocare Tech. and Krsnaa Diagnostics stand at 0.16%, 0.0%, 2.63% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 52.07 and 10.34 respectively.

Recommendations:
The current total number of analysts covering the stock stands at 25, Three months ago this number stood at 23. Out of total, 9 analyst have a'Strong Buy' reco, 12 analyst have a'Buy' reco, 1 analyst have a'Hold' reco, 3 analyst have a'Sell' reco.

Mean recommendations by 25 analyst stand at'Buy'.

Leadership of Dr Lal Pathlabs :
Ved Prakash Goel is Group Chief Financial Officer
Shankha Banerjee is Chief Executive Officer
Vinay Gujral is Co. Secretary & Compl. Officer
Arvind Lal is Executive Chairman
Vandana Lal is Whole Time Director
Archana Lal Erdmann is Non Executive Director
Rahul Sharma is Non Executive Director
Arun Duggal is Independent Director
Gurinder Singh Kalra is Independent Director
Rajit Mehta is Independent Director
Somya Satsangi is Independent Director
Rohit Bhasin is Independent Director

Show More

Industry

Key Indices Listed On

Nifty Smallcap 100, Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap

Address

Block E,Sector 18,New Delhi, Delhi - 110085

Contact

cs@lalpathlabs.com

https://www.lalpathlabs.com

Executive Leadership

AL

Arvind Lal

Executive Chairman

SB

Shankha Banerjee

Chief Executive Officer

VL

Vandana Lal

Whole Time Director

AL

Archana Lal Erdmann

Non Executive Director

Show More

Auditors

Deloitte Haskins & Sells LLP

FAQs about Dr Lal Pathlabs share

1. What's the Dr Lal Pathlabs share price today?
Dr Lal Pathlabs share price is Rs 1,598.10 as on 11 Jun, 2026, 11:31 AM IST. Dr Lal Pathlabs share price is up by 1.88% based on previous share price of Rs 1,575.8. Dr Lal Pathlabs share price trend:
- Last 12 Months: Dr Lal Pathlabs share price moved up 7.07%
- Last 3 Years: Dr Lal Pathlabs Share price moved up by 63.43%
2. What is Dr Lal Pathlabs's 52 week high / low?
52 Week high of Dr Lal Pathlabs share is Rs 1,770.00 while 52 week low is Rs 1,272.60
3. What are the returns for Dr Lal Pathlabs share?
Return Performance of Dr Lal Pathlabs Shares:
- 1 Week: Dr Lal Pathlabs share price moved up by 2.36%
4. What's the market capitalization of Dr Lal Pathlabs?
Dr Lal Pathlabs share has a market capitalization of Rs 26,825.56 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 8.
5. What is the PE & PB ratio of Dr Lal Pathlabs?
The PE ratio of Dr Lal Pathlabs stands at 52.07, while the PB ratio is 5.94.

Top Gainers

As on 11:27 AM | 11 Jun 2026

Aegis Logistics

887.80

86.80 (10.84%)

Blue Jet Healthcare

509.10

39.36 (8.38%)

DOMS Industries

2,235.40

116.81 (5.52%)

581.20

30.41 (5.52%)

1,933.10

100.10 (5.47%)

Top Losers

As on 11:27 AM | 11 Jun 2026

1,817.70

-73.90 (-3.91%)

1,147.20

-46.21 (-3.88%)

168.35

-6.56 (-3.75%)

Afcons Infrastru

318.80

-11.25 (-3.41%)

158.30

-5.32 (-3.26%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.